Literature DB >> 11444914

Mitochondrial dysfunction in cardiac disease: ischemia--reperfusion, aging, and heart failure.

E J Lesnefsky1, S Moghaddas, B Tandler, J Kerner, C L Hoppel.   

Abstract

Mitochondria contribute to cardiac dysfunction and myocyte injury via a loss of metabolic capacity and by the production and release of toxic products. This article discusses aspects of mitochondrial structure and metabolism that are pertinent to the role of mitochondria in cardiac disease. Generalized mechanisms of mitochondrial-derived myocyte injury are also discussed, as are the strengths and weaknesses of experimental models used to study the contribution of mitochondria to cardiac injury. Finally, the involvement of mitochondria in the pathogenesis of specific cardiac disease states (ischemia, reperfusion, aging, ischemic preconditioning, and cardiomyopathy) is addressed. Copyright 2001 Academic Press.

Entities:  

Mesh:

Year:  2001        PMID: 11444914     DOI: 10.1006/jmcc.2001.1378

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  238 in total

1.  Gypenosides alleviate myocardial ischemia-reperfusion injury via attenuation of oxidative stress and preservation of mitochondrial function in rat heart.

Authors:  Haijie Yu; Qigang Guan; Liang Guo; Haishan Zhang; Xuefeng Pang; Ying Cheng; Xingang Zhang; Yingxian Sun
Journal:  Cell Stress Chaperones       Date:  2016-01-22       Impact factor: 3.667

2.  Metabolism of hyperpolarized 13 C-acetoacetate to β-hydroxybutyrate detects real-time mitochondrial redox state and dysfunction in heart tissue.

Authors:  Wei Chen; Gaurav Sharma; Weina Jiang; Nesmine R Maptue; Craig R Malloy; A Dean Sherry; Chalermchai Khemtong
Journal:  NMR Biomed       Date:  2019-04-10       Impact factor: 4.044

Review 3.  The role of PGC-1 coactivators in aging skeletal muscle and heart.

Authors:  Lloye M Dillon; Adriana P Rebelo; Carlos T Moraes
Journal:  IUBMB Life       Date:  2012-01-25       Impact factor: 3.885

Review 4.  Mitochondria as a target in treatment.

Authors:  Marie-Céline Frantz; Peter Wipf
Journal:  Environ Mol Mutagen       Date:  2010-06       Impact factor: 3.216

5.  Electron flow into cytochrome c coupled with reactive oxygen species from the electron transport chain converts cytochrome c to a cardiolipin peroxidase: role during ischemia-reperfusion.

Authors:  Hema S Aluri; David C Simpson; Jeremy C Allegood; Ying Hu; Karol Szczepanek; Scott Gronert; Qun Chen; Edward J Lesnefsky
Journal:  Biochim Biophys Acta       Date:  2014-08-01

6.  Dityrosine, a protein product of oxidative stress, as a possible marker of acute myocardial infarctions.

Authors:  Felix Mayer; Sarah Pröpper; Stefanie Ritz-Timme
Journal:  Int J Legal Med       Date:  2014-05-13       Impact factor: 2.686

7.  Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial function.

Authors:  John W Elrod; John W Calvert; Joanna Morrison; Jeannette E Doeller; David W Kraus; Ling Tao; Xiangying Jiao; Rosario Scalia; Levente Kiss; Csaba Szabo; Hideo Kimura; Chi-Wing Chow; David J Lefer
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-18       Impact factor: 11.205

Review 8.  Potential therapeutic benefits of strategies directed to mitochondria.

Authors:  Amadou K S Camara; Edward J Lesnefsky; David F Stowe
Journal:  Antioxid Redox Signal       Date:  2010-08-01       Impact factor: 8.401

9.  Bacterial endotoxin lipopolysaccharide and reactive oxygen species inhibit Leydig cell steroidogenesis via perturbation of mitochondria.

Authors:  John A Allen; Thorsten Diemer; Paul Janus; Karen Held Hales; Dale B Hales
Journal:  Endocrine       Date:  2004-12       Impact factor: 3.633

Review 10.  Biochemical dysfunction in heart mitochondria exposed to ischaemia and reperfusion.

Authors:  Giancarlo Solaini; David A Harris
Journal:  Biochem J       Date:  2005-09-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.